NCT02298959 2026-04-13Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced CancerNational Cancer Institute (NCI)Phase 1 Active not recruiting59 enrolled
NCT04514484 2026-03-23Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVNational Cancer Institute (NCI)Phase 1 Active not recruiting8 enrolled